AMH vs AFC: What Do These Tests Tell You About Ovarian Reserve?
AMH and AFC are two of the most commonly discussed ovarian reserve tests. They are related, but they are not identical and neither is a direct test of egg quality. AMH is measured in blood and reflects hormone production from small ovarian follicles. AFC is measured by ultrasound and counts visible small antral follicles. In fertility care, both are used mainly to estimate ovarian response to stimulation and support treatment planning. The comparison becomes misleading when either result is treated as a simple score of a woman’s ability to become pregnant naturally.
What the AMH test measures
Anti-Mullerian hormone is produced by small growing follicles in the ovaries. Because the level generally relates to the number of recruitable follicles, it can help predict whether ovarian response to stimulation may be low or high. For related MotherToBe guidance, see low AMH treatment guide.
AMH can be measured on different days of the cycle, although laboratories and clinical context still matter. A result should be interpreted using the laboratory’s units and method rather than compared casually with online values.
What antral follicle count measures
AFC is assessed using transvaginal ultrasound, usually at an appropriate early-cycle time. The clinician counts small antral follicles visible in both ovaries.
The result gives an ultrasound view of the recruitable follicle cohort at that time. It can vary between cycles and depends partly on imaging quality and observer technique. Like AMH, AFC is useful for predicting ovarian response rather than guaranteeing pregnancy.
When AMH and AFC agree or differ
Often AMH and AFC point in the same direction, but discordant results occur. A clinician should not simply choose the more reassuring number.
Age, previous ovarian surgery, hormonal medication, PCOS and technical or laboratory variation can influence interpretation. If results differ substantially, ask whether repeating a test or relying on previous stimulation response would change management.
What ovarian reserve tests can predict
Their strongest clinical use is anticipating ovarian response in assisted conception. A lower reserve may predict fewer follicles or eggs during stimulation; a high reserve may predict a stronger response and help guide safety planning. For related MotherToBe guidance, see IVF treatment.
These tests can support medication decisions and counselling. They do not tell exactly how many eggs remain in the ovaries and cannot specify the number of months or years of fertility left.
What AMH and AFC cannot tell you
Neither test can directly measure egg quality or guarantee natural conception. Current guidance advises against using AMH to predict spontaneous pregnancy. Age remains an important predictor of reproductive potential. For related MotherToBe guidance, see natural conception with low AMH.
A low reserve result can coexist with natural conception, while a high AMH or AFC does not protect against tubal disease, sperm factors or other causes of infertility.
Using the results in a consultation
Ask what the test was ordered to answer. If IVF is being considered, discuss expected response, medication planning and how previous cycles influence the estimate. For related MotherToBe guidance, see Dr. S. Vyjayanthi.
If you are not infertile and are using AMH as a general fertility test, ask about its limitations before making major decisions. For a low result, MotherToBe’s low-AMH and IVF information provide useful context.
Related reading on MotherToBe
Low AMH treatment guide | Natural conception with low AMH | IVF treatment | Dr. S. Vyjayanthi
How this fits into your fertility plan
Use this as the ovarian-reserve explainer in the cluster. It should support, not compete with, the existing Low AMH commercial/informational page and the IVF service page. Avoid turning AMH or AFC into a fertility score.
For individual assessment, review the profile of Dr. S. Vyjayanthi, Director and Fertility Specialist at MotherToBe. Treatment decisions should be based on personal medical findings rather than a generic online pathway.
Frequently Asked Questions
What is the difference between AMH and AFC?
AMH is a blood hormone measurement, while AFC is an ultrasound count of small ovarian follicles. Both estimate ovarian reserve and treatment response.
Which is better, AMH or AFC?
Neither is universally better. They provide complementary information and should be interpreted with age and diagnosis.
Can AMH predict natural pregnancy?
No. Current guidance advises against using AMH as a predictor of spontaneous conception.
Can AFC predict natural pregnancy?
AFC is primarily an ovarian reserve and response marker and should not be treated as a standalone natural-pregnancy prediction.
Does low AMH mean poor egg quality?
No. AMH is not a direct egg-quality test.
Does low AFC mean infertility?
No. A low AFC may predict lower ovarian response but does not by itself diagnose infertility.
Can AMH and AFC be different?
Yes. Discordant results occur and should be interpreted clinically.
Can AFC change each month?
Yes. The visible follicle cohort can vary between cycles, and ultrasound technique also affects the count.
Can PCOS cause high AMH or AFC?
Many people with PCOS have more small follicles and may have higher AMH, but these findings alone do not diagnose PCOS.
Can AMH tell when menopause will happen?
A single AMH result is not a precise menopause countdown.
Can this result or treatment guarantee pregnancy?
No. Fertility outcomes depend on age, diagnosis, reproductive history, partner factors and treatment response. A test or procedure can guide care without guaranteeing pregnancy.
Should both partners be evaluated?
Yes, where applicable. Parallel assessment can identify male, female or combined factors and can prevent unnecessary delays in choosing treatment.
When should I see a fertility specialist?
Evaluation is generally advised after 12 months of trying when the woman is under 35 and after 6 months at 35 or older, with earlier review when a known fertility factor exists.
Can I rely on one test result?
Usually not. Fertility tests are interpreted together with age, symptoms, medical history, imaging, semen findings and previous treatment response.
Are online success rates personal predictions?
No. Clinic or study averages describe groups. Your individual prognosis may differ because age, diagnosis, embryo or sperm factors and treatment history vary.
Should I take supplements without asking my doctor?
No. Supplements can have side effects, interact with medicines and may not have evidence for the claim being made. Discuss them with the treating team.
Can lifestyle changes replace fertility treatment?
Healthy habits support general wellbeing, but they cannot reliably correct every fertility diagnosis. Treatment should address the cause identified in the evaluation.
What records should I bring to a consultation?
Bring previous scans, hormone reports, semen analyses, operative notes, fertility treatment records, medication lists and relevant pregnancy history.
When is IVF considered?
IVF may be discussed when the diagnosis, age, tubal or male factors, previous treatment or time considerations make it appropriate. It is not automatically required for every fertility problem.
Why is clinician review important before treatment?
A clinician can connect test results with your history, explain limitations, discuss alternatives and identify risks that cannot be assessed from general online information.
When to seek medical advice
Contact your fertility team if symptoms are severe, rapidly worsening or unexpected. Seek urgent medical care for severe pain, heavy bleeding, fainting, breathing difficulty, high fever or another acute concern. This article is educational and does not replace an individual diagnosis.
Next step: Book an appointment with MotherToBe
